Sun Pharma opens new plant in BD

Sun Pharmaceuticals (EZ) Ltd., a subsidiary of Sun Pharmaceutical Industries Limited (Sun Pharma), on Saturday announced the opening of a new manufacturing plant at Meghna Industrial Economic Zone in Narayanganj, says a press release.

The state-of-the-art facility is equipped with the latest technology and conforms to cGMP standards. It has an annual production capacity of approximately 1.0 billion tablets and capsules.

Salman F Rahman, Private Industry and Investment Adviser to the Prime Minister, inaugurated the plant in the presence of Pranay Verma, High Commissioner of India; Shaikh Yusuf Harun, Executive Chairman (Senior Secretary) of Bangladesh Economic Zones Authority; and Major General Mohammad Yousuf, Director General of Directorate General of Drug Administration (DGDA).

Mostafa Kamal, Chairman & Managing Director of Meghna Group of Industries; Dr Abdul Muktadir, President of Bangladesh Association of Pharmaceutical Industries and Chairman & MD of Incepta Pharmaceuticals Ltd; S M Shafiuzzaman, Secretary General of Bangladesh Association of Pharmaceutical Industries; and Prof Dr Firoj Ahmed Dean (Acting), Faculty of Pharmacy of University of Dhaka; were present as special guests.

For the past two decades, Sun Pharma has been dedicated to providing high-quality, affordable medicines to the people of Bangladesh. The new facility underscores this commitment by enhancing production capacity and creating new jobs in the country.

Mr Rahman praised Sun Pharma's efforts, highlighting its contribution to economic growth and innovation in the healthcare sector.

Sun Pharma is the world's fourth largest specialty generics company with presence in specialty, generics and consumer healthcare products. It is the largest pharmaceutical company in India and is a leading generic company in the US as well as global emerging markets.

Sun Pharma's high growth global specialty portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for over 16 per cent of company sales.

The company's vertically integrated operations deliver high-quality medicines, trusted by physicians and consumers in over 100 countries. Its manufacturing facilities are spread across six continents. Sun Pharma is proud of its multi-cultural workforce drawn from over 50 nations.